Paulson Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Paulson Wealth Management's GILD Position: Q2 2026 in Review
Paulson Wealth Management reduced its Gilead Sciences (GILD) stake by 0.55% in Q2 2026, selling an estimated $2.77K and leaving 3,818 shares worth $482K. The position accounts for 0.1% of the portfolio, ranked #84.
Paulson Wealth Management first reported a position in GILD in Q4 2017 and has held it in 21 quarters since. The position peaked at $535K in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Paulson Wealth Management held 3,818 shares of Gilead Sciences worth $482K as of Q2 2026.
- Paulson Wealth Management sold 21 Gilead Sciences shares in Q2 2026, an estimated $2.77K.
- Gilead Sciences made up 0.1% of Paulson Wealth Management's portfolio in Q2 2026, its #84 holding.
- Paulson Wealth Management first reported a position in Gilead Sciences in Q4 2017 and has held it in 21 quarters since.
- Paulson Wealth Management's Gilead Sciences position peaked at $535K in Q1 2026.
- 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Paulson Wealth Management's 13F filing for Q2 2026, filed 4 Aug 2026.